Attovia

Attovia

Clinical-stage biopharma developing biparatopic nanobodies

Overview

Preparing company summary.

About Attovia

Simplify's Rating
Why Attovia is rated
B-
Rated B on Competitive Edge
Rated B on Growth Potential
Rated C on Differentiation

Industries

Biotechnology

Healthcare

Company Size

51-200

Company Stage

Series C

Total Funding

$255M

Headquarters

Fremont, California

Founded

2023

People at Attovia

People at Attovia who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Phase 1 dosing of ATTO-1310 for chronic pruritus achieved in January 2025[1].
  • ATTO-3712 bispecific for atopic dermatitis Phase 1 trial is now active advancing pipeline[5].
  • $90M Series C funding secured in April 2025 to reach clinical proof-of-concept for lead assets[3].

What critics are saying

  • ATTO-1310 may fail Phase 2 efficacy versus lebrikizumab in 12–18 months with 40–50% risk[1][2].
  • Platform could not generalize beyond GPCRs due to off-target binding in 18–24 months with 35–45% risk[2].
  • Competitor Nanobel may launch superior bispecific in 12–15 months blocking ATTO-3712 market entry with 30–40% risk[3].

What makes Attovia unique

  • ATTOBODY platform engineers biparatopic nanobodies binding two sites on one target for ultra-high affinity[1][3].
  • Modular design enables tunable half-lives allowing quarterly or less frequent dosing unlike traditional antibodies[2][7].
  • Targets hard-to-drug GPCRs and inhibits multiple disease pathways within a single molecule[1][3][6].

Help us improve and share your feedback! Did you find this helpful?

Funding

Total Funding

$255M

Above

Industry Average

Funded Over

3 Rounds

Series C funding is usually for startups that are doing well and are looking for more money to fuel major growth, such as acquiring other companies, expanding into global markets, or launching new product lines. Investors typically include larger venture capital firms and private equity.
Series C Funding Comparison
Above Average

Industry standards

$50M
$50M
Medium
$62M
SeatGeek
$90M
Attovia
$100M
Oura

Benefits

Relocation Assistance

Growth & Insights

Headcount

6 month growth

0%

1 year growth

1%

2 year growth

8%

Recently Posted Jobs

Sign up to get curated job recommendations

Attovia is Hiring for 3 Jobs on Simplify!

Find jobs on Simplify and start your career today

Don't see your dream role? Check out thousands of other roles on Simplify. Browse all jobs →